Skip to main content

Advertisement

Log in

Prospective assessment of perioperative course in 2648 patients after surgical treatment of benign prostatic obstruction

  • Original Article
  • Published:
World Journal of Urology Aims and scope Submit manuscript

Abstract

Purpose

TUR-prostate (TUR-P) is considered the reference method for surgical treatment of benign prostatic obstruction (BPO); Greenlight laser photoselective vaporization (PVP) and thulium laser vapoenucleation (ThuVEP) have also been established as treatments of BPO. Objective of this prospective observation was to compare a large numbers of patients treated in everyday routine.

Methods

This prospective multicentre data collection assesses morbidity and perioperative course of consecutive men treated with BPO-related transurethral surgery between 2011 and 2014 in a German metropolis area with TUR-P, PVP or ThuVEP.

Results

Two thousand six hundred and forty-eight patients have been treated in the time period. All treatment options achieved immediate improvement of voiding parameters. Multivariate analyses proved shorter hospital stay after laser treatments as compared to resection (p < 0.001). In terms of hospital stay, the advantage of ThuVEP compared to TUR-P increased with prostate volume (p < 0.001). Patients with ongoing anticoagulation or bridging had prolonged hospital stay (p < 0.001). Overall adverse events were least frequent in PVP (p 0.016), as were Clavien 3b events (p < 0.001).

Conclusions

Surgical treatment of BPO is effective and safe independent of the surgical procedure. Volume reduction is most effective in ThuVEP; PVP has the lowest rate of severe complications. Laser treatment is associated with shorter hospital stay. Surgery under ongoing anticoagulation prolonged the post-operative hospital stay.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Gravas S, Bach T; Bachmann A, Drake M, Gacci M, Gratzke C, Madersbacher S, Mamoulakis C, Tikkinen KAO, Karavitakis M, Malde S, Sakkalis V, Umbach R (2016) EAU guidelines in treatment of non-neurogenic male LUTS. www.uroweb.org. 20th March 2016

  2. Thomas JA, Tubaro A, Barber N, Dáncona F, Muir G, Witzsch U, Grimm MO, Benejam J, Stolzenburg JU, Riddick A, Pahernik S, Roelink H, Amaye F, Saussine C, Bruyere F, Loidl W, Larner T, Gogoi NK, Hindley R, Muschter R, Thorpe A, Shroti N, Grahim S, Hamann M, Miller K, Schostak M, Capitán C, Knispel H, Bachmann A (2016) A multicenter randomized noninferiority trial comparing GreenLight-XPS laser vaporization of the prostate and transurethral resection of the prostate for the treatment of benign prostatic obstruction: two-yr. outcomes of the GOLIATH study. Eur Urol 69:94–102

    Article  PubMed  Google Scholar 

  3. Netsch C, Engbert A, Bach T, Gross AJ (2014) Long-term outcome following Thulium VapoEnucleation of the prostate. World J Urol 32:1551–1558

    Article  CAS  PubMed  Google Scholar 

  4. Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205–213

    Article  PubMed  PubMed Central  Google Scholar 

  5. Mitropoulos D, Artibani W, Graefen M, Remzi M, Roupret M, Truss M (2012) Reporting and grading of complications after urologic surgical procedures: an ad hoc EAU Guidelines panel assessment and recommendations. Eur Urol 61:341–349

    Article  PubMed  Google Scholar 

  6. Bach T, Netsch C, Pohlmann L, Herrman TR, Gross AJ (2010) Thulium:YAG laser enucleation in large volume prostates. J Urol 186:2323–2327

    Article  Google Scholar 

  7. Bachmann A, Tubaro A, Barber N, Dácona F, Muir G, Witzsch U, Grimmm MO, Benejam J, Stolzenburg JU, Riddick A, Pahernik S, Roelink H, Amaye F, Saussine C, Bruyére F, Loidl W, Larner T, Gogoi NK, Hindley R, Muschter R, Thorpe A, Shroti N, Graham S, Hamann M, Miller K, Schostak M, Capitán C, Knispel H, Thomas AJ, The GOLIATH study (2014) 180-W XPS Greenlight laser vaporisation versus transurethral resection of the prostate for the treatment of benign prostatic obstruction: 6-month safety and efficacy results of e European multicentre rendomised trail. Eur Urol 65:931–942

    Article  PubMed  Google Scholar 

  8. Cornu JN, Ahyai SA, Bachmann A, de la Rosette J, Gilling P, Gratzke C, McVary K, Novara G, Woo H, Madersbacher S (2015) A systematic review and meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic obstruction: an update. Eur Urol 67:1066–1096

    Article  PubMed  Google Scholar 

  9. Yang Z, Wang X, Liu T (2013) Thulium laser enucleation versus plasmakinetic resection of the prostate: a randomized prospective trial with 18-month follow-up. Urology 81:396–401

    Article  PubMed  Google Scholar 

  10. Ahyai SA, Gilling P, Kaplan SA, Kuntz RM, Madersbacher S, Montorsi F, Speakman MJ, Stief CG (2010) Meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic enlargement. Eur Urol 58:384–397

    Article  PubMed  Google Scholar 

  11. Netsch C, Tiburtius C, Bach T, Knipper S, Gross AJ (2014) Association of Prostate size and perioperative morbidity in thulium:YAG vapoenucleation of the prostate. Urol Int 93:22–28

    CAS  PubMed  Google Scholar 

  12. Gross AJ, Netsch C, Knipper S, Hölzel J, Bach T (2013) Complications and early postoperative outcome in 1080 patients after thulium vapoenucleation of the prostate: results at a single institution. Eur Urol 63:859–867

    Article  PubMed  Google Scholar 

  13. Reich O, Gratzke C, Bachmann A, Seitz M, Schlenker B, Hermanek P, Lack N, Stief CG (2008) Morbidity, mortality and early outcome of transurethral resection of the prostate: a prospective multicenter evaluation of 10654 patients. J Urol 180:246–249

    Article  PubMed  Google Scholar 

  14. Varkarakis I, Kyriakakis Z, Delis A, Protogerou V, Deliveliotis C (2004) Long-term results of open transvesical prostatectomy from a contemporary series of patients. Urology 64:306–310

    Article  PubMed  Google Scholar 

  15. Adam C, Hofstetter A, Deubner J et al (2004) Retropubic transvesical prostatectomy for significant prostatic enlargement must remain a standard part of urology training. Scand J Urol Nephrol 38:472–476

    Article  PubMed  Google Scholar 

  16. Serrat V, Morgia G, Fondacaro L et al., members of the Sicilian Calabrian Society of Urology (2002) Open prostatectomy for benign prostatic enlargement in southern Europe in the late 1990s: a contemporary series of 1800 interventions. Urology 60:623–627

Download references

Authors’ contribution

T. Bach developed the project and was involved in data management, data analysis and manuscript writing. F. Wölbling was involved in data collection and management and data analysis. A.J. Gross, C. Netsch, S. Tauber, T. Pottek and C. Wülfing were involved in manuscript editing. C. Brunken was involved in manuscript editing and data analysis.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Thorsten Bach.

Ethics declarations

Conflict of interest

None.

Ethical approval

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. For this type of study, formal consent is not required.

Additional information

Thorsten Bach and Felix Wölbling have contributed equally to this research.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bach, T., Wölbling, F., Gross, A.J. et al. Prospective assessment of perioperative course in 2648 patients after surgical treatment of benign prostatic obstruction. World J Urol 35, 285–292 (2017). https://doi.org/10.1007/s00345-016-1866-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00345-016-1866-7

Keywords

Navigation